Roger Stupp

  • 43763 Citations
1990 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Letter
2019

Leptomeningeal tumor response to combined MAPK/ERK inhibition in V600E-mutated gliomas despite undetectable CSF drug levels

Hottinger, A. F., Bensaid, D., De Micheli, R., Moura, B., Mokhtari, K., Cardoso, E., Idbaih, A. & Stupp, R., Jan 1 2019, In : Annals of Oncology. 30, 1, p. 155-156 2 p.

Research output: Contribution to journalLetter

2018

cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

Brat, D. J., Aldape, K., Colman, H., Holland, E. C., Louis, D. N., Jenkins, R. B., Kleinschmidt-DeMasters, B. K., Perry, A., Reifenberger, G., Stupp, R., von Deimling, A. & Weller, M., Nov 1 2018, In : Acta Neuropathologica. 136, 5, p. 805-810 6 p.

Research output: Contribution to journalLetter

97 Scopus citations

Hospital volume and group expertise in newly diagnosed glioblastoma management

Lukas, R. V., Lesniak, M. S. & Stupp, R., Jan 1 2018, In : Journal of Neuro-Oncology. 136, 1, p. 213-214 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

In reply

Stupp, R. & Ram, Z., May 1 2018, In : JAMA - Journal of the American Medical Association. 319, 17, 1 p.

Research output: Contribution to journalLetter

2 Scopus citations
2017

Evidence-based management of adult patients with diffuse glioma – Authors' reply

Weller, M., van den Bent, M., Tonn, J. C., Stupp, R., Preusser, M., Cohen-Jonathan-Moyal, E., Henriksson, R., Rhun, E. L., Balana, C., Chinot, O., Bendszus, M., Reijneveld, J. C., Dhermain, F., French, P., Marosi, C., Watts, C., Oberg, I., Pilkington, G., Baumert, B. G., Taphoorn, M. J. B. & 6 others, Hegi, M., Westphal, M., Reifenberger, G., Soffietti, R., Wick, W. & the European Association for Neuro-Oncology (EANO) Task Force on Gliomas, Aug 2017, In : The Lancet Oncology. 18, 8, p. e430-e431

Research output: Contribution to journalLetter

1 Scopus citations

Go, no-go decision making for phase 3 clinical trials: ACT IV revisited – Authors' reply

Weller, M., Butowski, N., Tran, D. D., Recht, L. D., Lim, M., Hirte, H., Ashby, L., Mechtler, L., Goldlust, S. A., Iwamoto, F., Drappatz, J., O'Rourke, D. M., Wong, M., Hamilton, M. G., Finocchiaro, G., Perry, J., Wick, W., Green, J., He, Y., Turner, C. D. & 5 others, Yellin, M. J., Keler, T., Davis, T. A., Stupp, R. & Sampson, J. H., Dec 2017, In : The Lancet Oncology. 18, 12, p. e709-e710

Research output: Contribution to journalLetter

3 Scopus citations
2016

Preoperative chemoradiotherapy with cisplatin and docetaxel for stage IIIB non-small-cell lung cancer: 10-year follow-up of the SAKK 16/01 trial

Früh, M., Ris, H. B., Xyrafas, A., Peters, S., Mirimanoff, R. O., Gautschi, O., Pless, M. & Stupp, R., Jan 1 2016, In : Annals of Oncology. 27, 10, p. 1971-1972 2 p.

Research output: Contribution to journalLetter

5 Scopus citations

Reply to F. Felix et al and M.F. Fay et al

Happold, C., Gorlia, T., Chinot, O., Gilbert, M. R., Nabors, L. B., Wick, W., Pugh, S. L., Hegi, M., Cloughesy, T., Roth, P., Reardon, D. A., Perry, J. R., Mehta, M. P., Stupp, R. & Weller, M., Sep 1 2016, In : Journal of Clinical Oncology. 34, 25, p. 3107-3108 2 p.

Research output: Contribution to journalLetter

Treatment for patients with newly diagnosed glioblastoma: In Reply

Stupp, R., Toms, S. A. & Kesari, S., Jun 7 2016, In : JAMA - Journal of the American Medical Association. 315, 21, p. 2348-2349 2 p.

Research output: Contribution to journalLetter

4 Scopus citations
2014

Addition of lomustine for bevacizumab-refractory recurrent glioblastoma

Tonder, M., Eisele, G., Weiss, T., Hofer, S., Seystahl, K., Valavanis, A., Stupp, R., Weller, M. & Roth, P., Oct 1 2014, In : Acta Oncologica. 53, 10, p. 1436-1440 5 p.

Research output: Contribution to journalLetter

5 Scopus citations

Does cilengitide deserve another chance?-Authors' reply

Stupp, R., Picard, M. & Weller, M., Jan 1 2014, In : The Lancet Oncology. 15, 13, p. e585-e586

Research output: Contribution to journalLetter

7 Scopus citations

Reply to M.C. Chamberlain

Gilbert, M. R., Dignam, J., Pugh, S., Armstrong, T. S., Wefel, J. S., Aldape, K., Stupp, R., Hegi, M., Won, M., Curran, W. J. & Mehta, M. P., May 20 2014, In : Journal of Clinical Oncology. 32, 15, p. 1634-1635 2 p.

Research output: Contribution to journalLetter

1 Scopus citations
2012

Personalised medicine in oncology: Questions for the next 20 years

Blay, J. Y., Lacombe, D., Meunier, F. & Stupp, R., May 1 2012, In : The Lancet Oncology. 13, 5, p. 448-449 2 p.

Research output: Contribution to journalLetter

15 Scopus citations

Treatment options in elderly patients with glioblastoma - Authors' reply

Malmström, A., Stupp, R., Hegi, M., Rosell, J. & Henriksson, R., Nov 1 2012, In : The Lancet Oncology. 13, 11

Research output: Contribution to journalLetter

2011

Trimodality therapy for locally advanced non-small-cell lung cancer: A curative approach

Stupp, R., Betticher, D., Ris, H. B., Peters, S. & Pless, M., Feb 10 2011, In : Journal of Clinical Oncology. 29, 5

Research output: Contribution to journalLetter

4 Scopus citations
2010

Bevacizumab and recurrent malignant gliomas: A European perspective

Wick, W., Weller, M., Van Den Bent, M. & Stupp, R., Apr 20 2010, In : Journal of Clinical Oncology. 28, 12, p. e188-e189

Research output: Contribution to journalLetter

87 Scopus citations

Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma [1]

Rossetti, A. O. & Stupp, R., Jan 1 2010, In : Neurology. 74, 16, 1 p.

Research output: Contribution to journalLetter

8 Scopus citations

Reply to M.C. Chamberlain

Stupp, R., Hegi, M. E., Neyns, B., Goldbrunner, R., Schlegel, U., Clement, P. M. J., Grabenbauer, G. G., Ochsenbein, A. F., Simon, M., Dietrich, P. Y., Pietsch, T., Hicking, C. B., Tonn, J. C., Diserens, A. C., Pica, A., Hermisson, M., Picard, M. & Weller, M., Nov 20 2010, In : Journal of Clinical Oncology. 28, 33, p. e696-e697

Research output: Contribution to journalLetter

2009

Will integrin inhibitors have proangiogenic effects in the clinic?

Weller, M., Reardon, D., Nabors, B. & Stupp, R., Jul 1 2009, In : Nature Medicine. 15, 7, 1 p.

Research output: Contribution to journalLetter

23 Scopus citations
2007

Informed consent: True information or institutional review board-approved disinformation? [1]

Rossel, M., Burnier, M. & Stupp, R., Dec 20 2007, In : Journal of Clinical Oncology. 25, 36, p. 5835-5836 2 p.

Research output: Contribution to journalLetter

In reply [2]

Stupp, R. & Hegi, M. E., Aug 10 2007, In : Journal of Clinical Oncology. 25, 23, p. 3550-3551 2 p.

Research output: Contribution to journalLetter

2005

Treatment of brain tumors

Paulino, A. C., Teh, B. S., Sadeh, M., Ashby, L., LaRocca, R., Ryken, T., Seiter, K., Aiken, R. D., Rutkowski, S., Ottensmeier, H., Pietsch, T., Stupp, R., Hegi, M. E. & DeAngelis, L. M., Jun 2 2005, In : New England Journal of Medicine. 352, 22, p. 2350-2353 4 p.

Research output: Contribution to journalLetter

9 Scopus citations
2002

Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide [4] (multiple letters)

Beauchesne, P., Stupp, R., Ostermann-Kraljevic, S., Dietrich, P. Y. & Mirimanoff, R. O., Jul 15 2002, In : Journal of Clinical Oncology. 20, 14, p. 3180-3181 2 p.

Research output: Contribution to journalLetter

4 Scopus citations

Treatment of newly diagnosed glioblastoma multiforme [3] (multiple letters)

Nieder, C., Stupp, R., Ostermann-Kraljevic, S., Dietrich, P. Y., Mirimanoff, R. O., Reardon, D. & Bigner, D. D., Jul 15 2002, In : Journal of Clinical Oncology. 20, 14

Research output: Contribution to journalLetter

2 Scopus citations